BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,355.20
      0.45%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.335
      -0.16%
      Bitcoin
      92,531.49
      0.61%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alkermes PLC (ALKS)

      7. Alkermes PLC (ALKS) Financials

      Alkermes PLC

      Alkermes PLC (ALKS)

      NASDAQ
      29.25
      -0.11
      (-0.37%)
      Closed November 26 4:00PM
      Delayed by 15 minutes
      29.25
      0.01
      (0.03%)
      After Hours: 4:02PM
      Delayed by 15 minutes

      Alkermes PLC Financial Summary

      The current ALKS market cap is 4.73B. The company's latest EPS is USD 2.1987 and P/E is 13.30.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 380.94M377.48M350.37M399.13M378.14M
      Operating Income 43.85M178.58M43.31M109.88M104.76M
      Net Income 47.76M112.78M36.83M91.36M92.38M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.17B1.04B1.17B1.11B1.66B
      Operating Income -175.48M-112.43M-29.29M-142.27M414.12M
      Net Income -196.62M-110.86M-48.17M-158.27M355.76M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.28B2.14B2.12B2.21B2.16B
      Total Liabilities 923.65M933.54M869.13M922.84M863.19M
      Total Equity 1.36B1.2B1.25B1.28B1.29B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 1.81B1.95B2.02B1.96B2.14B
      Total Liabilities 719.96M882.75M911.9M920.23M933.54M
      Total Equity 1.09B1.07B1.11B1.04B1.2B

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 294.12M401.35M21.11M167.14M248.73M
      Investing 74.34M53.36M-39.95M11.9M-97.43M
      Financing -13.22M-289.71M-17.87M-101.36M-212.47M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 72.08M82.84M101.72M21.04M401.35M
      Investing -141.83M-11.48M-66.2M-64.54M53.36M
      Financing 6.77M-2.17M29.07M-1.57M-289.71M

      Stats and Ratios

      Market Cap 4.73B
      Price to Earnings Ratio 13.30
      Price to Sales Ratio 2.84
      Price to Cash Ratio 10.34
      Price to Book Ratio 3.93
      Dividend Yield -

      Share Statistics

      Shares Outstanding 161.8M
      Average Volume (1 week) 1.81M
      Average Volume (1 Month) 1.65M
      52 Week Change 19.78%
      52 Week High 32.88
      52 Week Low 22.22
      Spread (Intraday) 1.09 (3.66%)

      Company Info

      Company Name Alkermes PLC
      Address connaught house
      dublin D04 C5Y6
      Website https://www.alkermes.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      ALKS
      Alkermes
      Delayed Upgrade Clock